Olaparib a new drug for genetic breast cancer article from The Times Online 6/1/09

BRCA NEWSWORTHY

New drug olaparib offers hope to women with genetic breast cancer by David Rose

Follow this link: http://www.timesonline.co.uk/tol/life_and_style/health/article6400852.ece

Olaparib is made by AstraZeneca & is being used in clinical trials to treat & or prevent cancer in high risk or BRCA families. They feel this drug is very promising in blocking the protein that makes cancer cells –causing only the cancer cell to either die or shrink. (BRCA patients have the mutated gene that is supposed to repair or fix damaged DNA—therefore when the repair doesn’t work properly mistakes in the DNA accumulate, do not repair & cancer develops.)

One comment

• 

  Lyn on 5 June 2009

  Amazing & wonderful news!

  Log in to Reply